Your medication may work differently in extreme heat because high temperatures physically degrade the active ingredients in many drugs and because dozens of common prescriptions interfere with your body’s ability to cool itself. These are two distinct problems, and both can be dangerous. Lorazepam, a benzodiazepine widely prescribed for anxiety and seizures, loses up to 75 percent of its potency when stored at body temperature for 210 days, according to research published in the journal Prehospital Emergency Care. That means a pill you depend on could be doing a fraction of its job if it spent the summer in a hot bathroom cabinet or a car glove box. For people managing dementia, brain health conditions, or the complex medication regimens that often accompany aging, the stakes are even higher.
But degradation is only half the story. A separate and arguably more urgent concern is that many medications — including antipsychotics, antidepressants, diuretics, and beta-blockers — actively undermine the physiological mechanisms your body uses to survive heat. They block sweating, reduce blood flow to the skin, or disrupt the brain’s internal thermostat. A 2024 systematic review in The Lancet eClinicalMedicine confirmed that both prescription and over-the-counter medications can raise core body temperature during heat stress. Heat-related deaths in the United States have increased 117 percent since 1999, and the medication connection is one of the least discussed reasons why. This article covers how heat physically breaks down specific drugs, which medication classes impair your heat response, why sun sensitivity adds a third layer of risk, and what practical steps caregivers and patients can take before the next heat wave arrives.
Table of Contents
- How Does Extreme Heat Physically Degrade Your Medications?
- Which Common Medications Impair Your Body’s Ability to Handle Heat?
- Sun Sensitivity and Photosensitivity Reactions From Medications
- How to Store and Protect Medications During Heat Waves
- Why Dementia Patients Face Compounded Heat and Medication Risks
- New Research and the CALOR List for Clinicians
- Preparing for a Future With More Extreme Heat
- Conclusion
- Frequently Asked Questions
How Does Extreme Heat Physically Degrade Your Medications?
Most over-the-counter and prescription medications are formulated for storage between 68 and 77 degrees Fahrenheit with 35 to 45 percent relative humidity. That narrow window exists for a reason. Chemical compounds in tablets, liquids, and injectables begin to break down when temperatures climb beyond their intended range, and the loss is not always visible. You will not necessarily see a color change or smell something off. The drug simply stops working as well. In a study of medications carried by emergency medical services, diazepam retained roughly 97 percent of its concentration after 120 days at elevated temperatures — a modest decline. Lorazepam, by contrast, dropped to just 86.5 percent of its original concentration in the same period and lost far more over longer exposure. These are not obscure drugs. They are among the most commonly used medications in dementia care and emergency seizure management.
The problem extends well beyond pills. Insulin degrades when left outside of refrigeration, which matters enormously for the many older adults managing both cognitive decline and diabetes. EpiPens may malfunction or deliver less epinephrine after heat exposure, turning a lifesaving device into an unreliable one. Pressurized inhalers can burst or fail when stored in a car trunk during summer. And atropine, used in cardiac emergencies, became undetectable after just four weeks of heat exposure in a National Park Service study of prehospital medication storage. The CDC now explicitly warns against leaving any medication in a car, mailbox, or other unshaded location during hot weather — advice that sounds simple but is routinely ignored. A useful comparison: think of medication storage the way you think of food safety. You would not eat chicken that sat in a hot car for six hours, even if it looked fine. The same logic applies to a bottle of blood pressure medication that rode around in your purse all day in July. The damage is chemical, not cosmetic, and by the time you notice a problem — a seizure that is not controlled, blood sugar that will not come down — the window for easy correction may have closed.
Which Common Medications Impair Your Body’s Ability to Handle Heat?
Your body cools itself through two primary mechanisms: sweating and increasing blood flow to the skin. Several classes of widely prescribed medications interfere with one or both of these processes. Anticholinergic drugs — a category that includes certain allergy medications, bladder control drugs, and some older antidepressants — block sweating directly. Without sweat, your body loses its most effective cooling tool. Beta-blockers, prescribed for high blood pressure and heart conditions, reduce heart rate and blood flow to the skin, limiting the body’s ability to radiate heat outward. Diuretics, another mainstay of blood pressure and heart failure treatment, cause fluid and electrolyte loss that accelerates dehydration in hot conditions. The CDC specifically notes that combining an ACE inhibitor or ARB with a diuretic significantly amplifies heat-related harm, a combination that is extremely common among older adults. For people with dementia or other neurological conditions, the picture is particularly concerning.
Antipsychotics such as haloperidol and chlorpromazine — frequently prescribed for agitation in dementia — impair the brain’s thermoregulation center, directly increasing heatstroke risk. Antidepressants, especially SSRIs and SNRIs, interfere with hypothalamic temperature regulation, raising the likelihood of heat exhaustion. Stimulants prescribed for ADHD raise body temperature and metabolic rate. None of these effects are theoretical. They are well-documented pharmacological actions that become acutely dangerous when ambient temperatures rise. However, the risk is not uniform, and this is where caregivers need to resist the impulse to stop medications without medical guidance. A person on a low-dose beta-blocker in a well-air-conditioned home faces a very different risk profile than someone on multiple heat-sensitizing drugs who spends time outdoors. The danger is highest when several of these medications overlap in the same patient — and in dementia care, polypharmacy is the norm, not the exception. The right response is not to discontinue drugs unilaterally but to have an explicit conversation with a prescriber about heat season planning, including whether doses should be adjusted or monitoring increased.
Sun Sensitivity and Photosensitivity Reactions From Medications
Beyond degradation and thermoregulation, a third heat-adjacent risk gets far less attention than it deserves: drug-induced photosensitivity. Certain medications make your skin dramatically more reactive to ultraviolet light, causing sunburn-like rashes, blistering, or lasting discoloration even with brief sun exposure. Tetracycline antibiotics, fluoroquinolones like ciprofloxacin, and metronidazole are well-known culprits. Antifungal drugs including griseofulvin and voriconazole also increase UV sensitivity significantly. For a person with dementia who may wander outdoors or who cannot reliably communicate discomfort, photosensitivity reactions can go unnoticed until they are severe. A caregiver might apply sunscreen in the morning, but a photosensitive reaction can develop even with moderate protection, especially during peak UV hours.
The practical implication is that anyone on these medications needs more than standard sun precautions — they need shade, protective clothing, and ideally limited midday outdoor exposure during summer months. This is not about comfort. Severe photosensitivity reactions can lead to secondary infections, hospitalizations, and significant pain in a population already managing considerable medical complexity. One important limitation: photosensitivity risk varies widely between individuals. Two people on the same antibiotic may have entirely different reactions to the same amount of sun exposure. Skin tone, other medications, hydration status, and the specific formulation all play a role. This unpredictability is precisely why a conservative approach — assuming the risk is real until proven otherwise — makes more sense than waiting for a reaction to occur.
How to Store and Protect Medications During Heat Waves
The CDC and FDA guidelines on medication storage during heat are straightforward but require active effort. Medications should be kept at room temperature, between 68 and 77 degrees Fahrenheit, unless the label specifies refrigeration. Never leave medications in a car, even briefly. A parked car’s interior can reach 130 degrees Fahrenheit or higher within an hour, well beyond the threshold that degrades most drugs. Mailboxes are another overlooked hazard — mail-order prescriptions delivered on a 100-degree day may sit in a metal box for hours before retrieval. For caregivers managing someone’s medication regimen, the tradeoff is between convenience and safety. A weekly pill organizer sitting on a kitchen counter near a window is convenient but potentially exposed to heat and light.
A cool, dark cabinet is safer but may be less accessible for someone with mobility issues. One practical approach is to use insulated medication bags when transporting drugs and to set a phone reminder to bring in mail-order medications immediately upon delivery. For insulin and other refrigerated drugs, a small travel cooler with ice packs is not optional during summer — it is essential equipment. Clinicians have additional responsibilities during heat waves. The CDC recommends that prescribers consider adjusting medication dose or frequency during extreme heat events, individualized by drug class and symptom severity. Patients on diuretics combined with ACE inhibitors or ARBs need extra monitoring. This kind of proactive adjustment is still uncommon in practice, which means caregivers may need to initiate the conversation rather than wait for a provider to bring it up.
Why Dementia Patients Face Compounded Heat and Medication Risks
People with dementia are disproportionately vulnerable to heat-medication interactions for reasons that go beyond their prescriptions. Cognitive impairment means they may not recognize the signs of overheating — flushed skin, dizziness, confusion — or may be unable to articulate that something feels wrong. Confusion caused by heat exhaustion can look almost identical to a dementia flare, leading caregivers to misattribute a medical emergency to the underlying condition. This diagnostic overlap is genuinely dangerous and has contributed to preventable deaths. The medication burden in dementia care amplifies the problem. A typical patient might be taking an antipsychotic for agitation, an SSRI for depression, a beta-blocker for blood pressure, and a diuretic for fluid retention. Every one of those drugs appears on the list of medications that impair heat response. The compounding effect is not simply additive — the risks interact.
A diuretic depletes fluid volume. An anticholinergic blocks sweating. A beta-blocker limits compensatory cardiac output. Layer these together in a 90-degree apartment with unreliable air conditioning, and you have a medical crisis in formation. One critical warning: do not assume that staying indoors eliminates the risk. Indoor heat-related deaths are common, particularly among older adults living alone or in facilities with inadequate cooling. The 702 heat-related deaths that occurred annually in the United States between 2004 and 2018 included many people who never went outside. Forty-one percent of those deaths had heat exposure as a contributing rather than primary cause, with cardiovascular diseases underlying 49 percent of them — exactly the conditions treated by the heat-sensitizing medications described above.
New Research and the CALOR List for Clinicians
The medical community is beginning to take the heat-medication nexus more seriously. The ADAPT-HEAT project, a collaboration between the University of Cologne and Hannover Medical School, is developing the CALOR list — a consensus-based directory designed to help clinicians quickly identify and manage medications that become hazardous during extreme heat. A panel of 30 interdisciplinary experts across Germany contributed to its development, and its publication represents one of the first structured clinical tools for this specific problem.
Closer to home, the National Weather Service partnered with CVS Health to raise public awareness about heat’s impact on medications, signaling that the issue is moving from academic journals into mainstream health communication. For caregivers and families, these developments are worth tracking. As heat waves become more frequent and more intense, the intersection of pharmacology and climate is no longer a niche concern — it is a core safety issue for anyone managing chronic medications.
Preparing for a Future With More Extreme Heat
Heat-related deaths in the United States have increased by 16.8 percent per year from 2016 to 2023, according to research published in JAMA. That trajectory is not slowing. For the millions of Americans managing dementia, cardiovascular disease, mental health conditions, and other chronic illnesses requiring daily medication, every successive summer brings compounding risk. The drugs that keep these conditions manageable are the same drugs that make heat more dangerous, and there is no pharmacological workaround that resolves this tension entirely.
What can change is preparedness. Medication heat plans — developed with a prescriber before summer begins — should become as routine as flu shot reminders. These plans should identify which drugs in a patient’s regimen carry heat risk, establish thresholds for dose adjustment, and outline monitoring steps for caregivers. The clinical infrastructure for this kind of planning is still catching up, but families and caregivers do not need to wait for it. A printed list of heat-sensitizing medications, taped to the refrigerator alongside emergency numbers, costs nothing and could prevent a crisis.
Conclusion
Extreme heat threatens medication effectiveness through two distinct pathways: it physically degrades drugs that are stored outside their intended temperature range, and it collides with the pharmacological effects of medications that impair sweating, fluid balance, thermoregulation, and cardiovascular compensation. For people living with dementia and their caregivers, these risks are compounded by cognitive impairment that masks early warning signs, by polypharmacy regimens that stack multiple heat-sensitizing drugs, and by living situations that may not guarantee reliable cooling. The practical response is layered.
Store all medications within their recommended temperature range and never leave them in cars or mailboxes. Talk with prescribers before heat season about which drugs carry heat risk and whether adjustments are warranted. Monitor for heat illness aggressively, knowing that its symptoms can mimic dementia progression. And recognize that this is not a problem with a one-time fix — it requires seasonal vigilance, every year, for as long as the medications are part of daily life.
Frequently Asked Questions
Can I put my medications in the refrigerator to keep them cool during a heat wave?
Not unless the label specifically says to refrigerate. Many medications are sensitive to moisture and cold as well as heat. Refrigerators can also expose drugs to condensation. The safest approach is a cool, dry, dark cabinet away from windows and appliances that generate heat.
How can I tell if my medication has been damaged by heat?
Sometimes you cannot. Tablets may become discolored, crumbly, or sticky. Liquids may change consistency. But many degraded medications look and smell normal. If you suspect heat exposure — for example, a prescription left in a hot car or delivered to a sun-baked mailbox — contact your pharmacist about a replacement rather than guessing.
Should I stop taking my blood pressure medication during a heat wave?
Never stop or adjust prescription medications without consulting your doctor. While diuretics, beta-blockers, and ACE inhibitors can increase heat vulnerability, stopping them abruptly carries its own serious risks, including rebound hypertension or heart failure. The right move is a conversation with your prescriber about heat-season adjustments.
Are generic medications more susceptible to heat damage than brand-name versions?
Not inherently. Both generic and brand-name drugs must meet the same FDA stability requirements. However, storage conditions during shipping and handling vary, and mail-order medications of any type are vulnerable to heat exposure during delivery. The risk is about the supply chain, not the formulation.
My loved one with dementia takes an antipsychotic. What should I watch for during hot weather?
Watch for flushed or unusually dry skin, rapid pulse, confusion beyond their baseline, nausea, and failure to sweat even when visibly warm. Antipsychotics impair the brain’s thermoregulation center, so the usual early warning signs of overheating may be blunted or absent. When in doubt, move them to a cool environment and contact their care team.
Does humidity make the medication-heat problem worse?
Yes, on both fronts. High humidity accelerates chemical degradation of some medications and makes it harder for the body to cool itself through sweat evaporation. The standard storage recommendation of 35 to 45 percent relative humidity exists precisely because moisture and heat together are more destructive than either alone.
